Chesnara plc (LON:CSN - Get Free Report) insider Steve Murray bought 7,874 shares of the business's stock in a transaction on Friday, April 26th. The stock was purchased at an average cost of GBX 252 ($3.11) per share, with a total value of £19,842.48 ($24,508.99).
Chesnara Price Performance
CSN traded down GBX 0.50 ($0.01) during midday trading on Friday, hitting GBX 252 ($3.11). The stock had a trading volume of 295,257 shares, compared to its average volume of 147,081. The company has a market cap of £380.14 million, a P/E ratio of -741.18 and a beta of 0.39. The business has a fifty day moving average of GBX 260.13 and a 200 day moving average of GBX 260.58. The company has a debt-to-equity ratio of 58.24, a quick ratio of 38.06 and a current ratio of 2.38. Chesnara plc has a 1 year low of GBX 242.70 ($3.00) and a 1 year high of GBX 290 ($3.58).
Chesnara Increases Dividend
The company also recently disclosed a dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Thursday, April 11th will be issued a GBX 15.61 ($0.19) dividend. This is an increase from Chesnara's previous dividend of $8.36. The ex-dividend date of this dividend is Thursday, April 11th. This represents a yield of 5.96%. Chesnara's dividend payout ratio is -7,058.82%.
Chesnara Company Profile
(
Get Free Report)
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through UK, Movestic, Waard Group, and Scildon segments. The company underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management, as well as general insurance products.
Read More
Before you consider Chesnara, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chesnara wasn't on the list.
While Chesnara currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
